메뉴 건너뛰기




Volumn 68, Issue 4, 2010, Pages 403-411

Factors responsible for "aspirin resistance" - Can we identify them?

Author keywords

Aspirin resistance; PFA 100; Platelets; Stable coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; COLLAGEN;

EID: 77953758395     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (25)
  • 1
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002; 324: 71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 2
    • 0037046196 scopus 로고    scopus 로고
    • Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    • Eikelboom JW, Hirsh J, Weitz JI et al. Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 2002; 105: 1650-1655.
    • (2002) Circulation , vol.105 , pp. 1650-1655
    • Eikelboom, J.W.1    Hirsh, J.2    Weitz, J.I.3
  • 3
    • 38949119325 scopus 로고    scopus 로고
    • Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
    • Krasopoulos G, Brister SJ, Beattie WS et al. Aspirin " resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ, 2008; 336: 195-198.
    • (2008) BMJ , vol.336 , pp. 195-198
    • Krasopoulos, G.1    Brister, S.J.2    Beattie, W.S.3
  • 4
    • 0035421783 scopus 로고    scopus 로고
    • Profile and prevalence of aspirin resistance in patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K, Poggio E et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol, 2001; 88: 230-235.
    • (2001) Am J Cardiol , vol.88 , pp. 230-235
    • Gum, P.A.1    Kottke-Marchant, K.2    Poggio, E.3
  • 5
    • 33846235920 scopus 로고    scopus 로고
    • Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
    • Hovens MM, Snoep JD, Eikenboom JC et al. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J, 2007; 153: 175-181.
    • (2007) Am Heart J , vol.153 , pp. 175-181
    • Hovens, M.M.1    Snoep, J.D.2    Eikenboom, J.C.3
  • 7
    • 84889732880 scopus 로고    scopus 로고
    • Nieprawidłowa odpowiedź na kwas acetylosalicylowy - Definicje i zasady postȩpowania w świetle poznanych czynników ryzyka
    • Postuła M, Kapłon-Cieślicka A, Rosiak M et al. Nieprawidłowa odpowiedź na kwas acetylosalicylowy - definicje i zasady postȩpowania w świetle poznanych czynników ryzyka. Kardiol Pol, 2008; 66: 313-319.
    • (2008) Kardiol Pol , vol.66 , pp. 313-319
    • Postuła, M.1    Kapłon-Cieślicka, A.2    Rosiak, M.3
  • 8
    • 18144377710 scopus 로고    scopus 로고
    • Prevalence of aspirin resistance measured by PFA-100®
    • Coma-Canella I, Velasco A, Castano S. Prevalence of aspirin resistance measured by PFA-100®. Int J Cardiol, 2005; 101: 71-76.
    • (2005) Int J Cardiol , vol.101 , pp. 71-76
    • Coma-Canella, I.1    Velasco, A.2    Castano, S.3
  • 9
    • 0036344893 scopus 로고    scopus 로고
    • Clinical application of the PFA-100®
    • Favaloro E. Clinical application of the PFA-100®. Curr Opin Hematol, 2002; 9: 407-415.
    • (2002) Curr Opin Hematol , vol.9 , pp. 407-415
    • Favaloro, E.1
  • 10
    • 0037669056 scopus 로고    scopus 로고
    • Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100®?
    • Watała C, Golański J, Rozalski M et al. Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100®? Thromb Res, 2003; 109: 299-306.
    • (2003) Thromb Res , vol.109 , pp. 299-306
    • Watała, C.1    Golański, J.2    Rozalski, M.3
  • 11
    • 33846932054 scopus 로고    scopus 로고
    • Clinical relevance of aspirin resistance in patients with stable coronary artery disease: A prospective follow-up study (PROSPECTAR)
    • Pamukcu B, Oflaz H, Onur I et al. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). Blood Coagul Fibrinolysis 2007; 18: 187-192.
    • (2007) Blood Coagul Fibrinolysis , vol.18 , pp. 187-192
    • Pamukcu, B.1    Oflaz, H.2    Onur, I.3
  • 12
    • 27444431936 scopus 로고    scopus 로고
    • Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
    • Borna C, Lazarowski E, van Heusden C et al. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels Thromb J, 2005; 3: 10-19.
    • (2005) Thromb J , vol.3 , pp. 10-19
    • Borna, C.1    Lazarowski, E.2    Van Heusden, C.3
  • 13
    • 0034054309 scopus 로고    scopus 로고
    • Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin
    • Kawasaki T, Ozeki Y, Igawa T et al. Increased sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke, 2000; 31: 591-595. (Pubitemid 30131641)
    • (2000) Stroke , vol.31 , Issue.3 , pp. 591-595
    • Kawasaki, T.1    Ozeki, Y.2    Igawa, T.3    Kambayashi, J.-I.4
  • 14
    • 0037101578 scopus 로고    scopus 로고
    • Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
    • Macchi L, Christiaens L, Brabant S et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res, 2002; 107: 45-49.
    • (2002) Thromb Res , vol.107 , pp. 45-49
    • Macchi, L.1    Christiaens, L.2    Brabant, S.3
  • 15
    • 33747088257 scopus 로고    scopus 로고
    • Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance
    • Frelinger AL, Furman MI, Linden MD et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation, 2006; 113: 2888-2896.
    • (2006) Circulation , vol.113 , pp. 2888-2896
    • Frelinger, A.L.1    Furman, M.I.2    Linden, M.D.3
  • 16
    • 0031895889 scopus 로고    scopus 로고
    • Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease
    • Carney RM, Freedland KE, Eisen SA et al. Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med, 1998; 24: 35-39.
    • (1998) Behav Med , vol.24 , pp. 35-39
    • Carney, R.M.1    Freedland, K.E.2    Eisen, S.A.3
  • 17
    • 0033578986 scopus 로고    scopus 로고
    • The rate of acetylsalicylic acid non-respondents among patients hospitalised for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis
    • Tarjan J, Salamon A, Jager R et al. The rate of acetylsalicylic acid non-respondents among patients hospitalised for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis. Orv Hetil, 1999; 140: 2339-2343.
    • (1999) Orv Hetil , vol.140 , pp. 2339-2343
    • Tarjan, J.1    Salamon, A.2    Jager, R.3
  • 18
    • 16844362580 scopus 로고    scopus 로고
    • Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
    • Schwartz KA, Schwartz DE, Ghosheh K et al. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol, 2005; 95: 973-975.
    • (2005) Am J Cardiol , vol.95 , pp. 973-975
    • Schwartz, K.A.1    Schwartz, D.E.2    Ghosheh, K.3
  • 19
    • 10744228434 scopus 로고    scopus 로고
    • Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
    • Cotter G, Shemesh E, Zehavi M et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J, 2004; 147: 293-300.
    • (2004) Am Heart J , vol.147 , pp. 293-300
    • Cotter, G.1    Shemesh, E.2    Zehavi, M.3
  • 20
    • 24944468330 scopus 로고    scopus 로고
    • The role of exercise on platelet aggregation in patients with stable coronary artery disease: Exercise induces aspirin resistant platelet activation
    • Pamukcu B, Oflaz H, Acar R et al. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis, 2005a; 20: 17-22.
    • (2005) J Thromb Thrombolysis , vol.20 , pp. 17-22
    • Pamukcu, B.1    Oflaz, H.2    Acar, R.3
  • 21
    • 0036878918 scopus 로고    scopus 로고
    • Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease
    • Christiaens L, Macchi L, Herpin D et al. Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease. Thromb Res, 2002; 108: 115-119.
    • (2002) Thromb Res , vol.108 , pp. 115-119
    • Christiaens, L.1    Macchi, L.2    Herpin, D.3
  • 22
    • 17444366978 scopus 로고    scopus 로고
    • Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease
    • Sestito A, Maccallini A, Sgueglia GA et al. Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thrombosis Res, 2005: 116: 25-31.
    • (2005) Thrombosis Res , vol.116 , pp. 25-31
    • Sestito, A.1    Maccallini, A.2    Sgueglia, G.A.3
  • 23
    • 0028288681 scopus 로고
    • Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
    • Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation, 1994; 89: 1951-1957. (Pubitemid 24142768)
    • (1994) Circulation , vol.89 , Issue.5 , pp. 1951-1957
    • Larsson, P.T.1    Wallen, N.H.2    Hjemdahl, P.3
  • 24
    • 0031013712 scopus 로고    scopus 로고
    • Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin
    • Santos MT, Valles J, Aznar J et al. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation, 1997; 95: 63-68.
    • (1997) Circulation , vol.95 , pp. 63-68
    • Santos, M.T.1    Valles, J.2    Aznar, J.3
  • 25
    • 0345131724 scopus 로고    scopus 로고
    • Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity
    • Valles J, Santos MT, Aznar J et al. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation, 1998; 97: 350-355
    • (1998) Circulation , vol.97 , pp. 350-355
    • Valles, J.1    Santos, M.T.2    Aznar, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.